Autopsy report · NCT03101098

Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus

“IRB did not approve this study.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 54 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Kangbuk Samsung Hospital

Sponsor type

University, hospital or other

Conditions

Hysterectomy

Interventions

Retroperitoneal liagation of uterine artery; Classical ligation of uterine artery

Participants

54 (planned, not actual)

Sites

1

Countries

South Korea

Trials that died the same way

• Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease
  “Study did not receive IRB approval.” (89% match in meaning)
• Light Therapy to Treat Depression in Pediatric Stem Cell Therapy Recipients
  “The study did not enroll participants and had not shown significant progress since the initial IRB approval.” (81% match in meaning)
• Study Comparing Intubation Via Video Laryngeal Mask Airways (VLMAs) Versus Video Laryngoscopy
  “Study never approved by the IRB. Was not initiated” (81% match in meaning)
• Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  “This study was never submitted to the IRB for review and approval. No research subjects were enrolled. .” (80% match in meaning)
• Antibiotics and Tissue Expanders in Breast Reconstruction
  “The study was withdrawn prior to IRB approval.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.